Most Recent
The Australian Patent Office has shot down a challenge by SNF to a BASF application for a mining patent.
A judge has signed off on a $19.25 million settlement in a shareholder class action brought against directors of defunct laser technology company Arasor International Ltd and partners in auditing firm Grant Thornton South Australia, but cut the legal fees of Squire Patton Boggs and Piper Alderman by $250,000.
A judge has signed off on a multi-million dollar settlement in a class action by retirees who claim they lost $27 million with the collapse of property lender Wickham Securities
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex' consultant took the brunt of it.
An Aboriginal art and souvenir supplier says its business has taken a hit since the ACCC accused it of selling fakes, and the company wants to expedite the regulator's case to avoid further damage, a court heard Wednesday.
A former NAB financial adviser has been permanently banned from providing financial services after an ASIC investigation found he fleeced clients out of at least $2 million.
A former RMIT worker suing the university for allegedly firing him after he blew the whistle on a colleague for selling exam answers to students has won a bid to subpoena documents from the Victorian Ombudsman.
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.
A barrister for the Australian Writers’ Guild has blasted documents produced by the non-profit Screenrights in a court battle over tens of millions of dollars in royalties payments, calling the evidence a "complete mishmash".
Two high ranking analysts from S&P Global have distanced themselves from the decision making process at the heart of a class action over toxic financial products given healthy ratings by the agency ahead of the global financial crisis.